Cancer and Genetics: Part III

Martha Weinar

Claire Alexander

Gayle A. Seely

ONF 2004, 31(2), 195-196. DOI: 10.1188/04.ONF.195-196

Jump to a section


    American Gastroenterological Association. (2001). Hereditary colorectal cancer and genetic testing [Position statement]. Gastroenterology, 121, 195-197.

    American Society of Clinical Oncology. (2003). Genetic testing for cancer susceptibility [Position statement]. Journal of Clinical Oncology, 21, 1-10.

    Borum, M. (2001). Colorectal cancer screening. Primary Care: Clinics in Office Practice, 28, 661-675.

    Brose, M., Rebbeck, T., Calzone, K., Stopfer, J., Nathanson, K., & Weber, B. (2002). Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. Journal of the National Cancer Institute, 94, 1365-1372.

    Claus, E., Risch, N., & Thompson, D. (1993a). Autosomal dominant inheritance of early-onset breast cancer—Implications for risk prediction. Cancer, 73, 643-651.

    Claus, E., Risch, N., & Thompson, D. (1993b). The calculation of breast cancer risk for women with a first-degree family history of ovarian cancer. Breast Cancer Research and Treatment, 28, 115-120.

    Domchek, S., Eisen, A., Calzone, K., Stopfer, J., Blackwood, A., & Weber, B. (2003). Application of breast cancer risk in clinical practice. Journal of Clinical Oncology, 21, 593-601.

    Euhus, D., Smith, K., Robinson, L., Stucky, A., Olopade, O., Cummings, S., et al. (2002). Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. Journal of the National Cancer Institute, 94, 844-851.

    Frank, T., & Critchfield, G. (2002). Hereditary risk of women's cancers. Best Practice and Research Clinical Obstetrics and Gynaecology, 16, 703-713.

    Ivanovich, J., Read, T., Ciske, D., Kodner, J., & Whelan, A. (1999). A practical approach to familial and hereditary colorectal cancer. American Journal of Medicine, 107, 68-77.

    Leventhal, H., Kelly, K., & Leventhal, E. (1999). Population risk, actual risk, perceived risk, and cancer control: Discussion. Journal of the National Cancer Institute Monographs, 25, 81-85.

    Lynch, H., & Chapelle, A. (1999). Genetic susceptibility to non-polyposis colorectal cancer. Journal of Medical Genetics, 36, 801-818.

    Mahon, S. (1998). Cancer risk assessment: Conceptual considerations for clinical practice. Oncology Nursing Forum, 25, 1535-1547.

    Narod, S. (2002). Modifiers of risk of hereditary breast and ovarian cancer. Nature Reviews Cancer, 2, 113-123.

    Offit, K., Levran, O., Mullaney, B., Mah, K., Nafa, K., Batish, S., et al. (2003). Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. Journal of the National Cancer Institute, 95, 1548-1551.

    Oncology Nursing Society. (2000). Cancer predisposition genetic testing and risk assessment counseling [Position statement]. Oncology Nursing Forum, 27, 1349.

    Rhodes, D. (2002). Identifying and counseling women at increased risk for breast cancer. Mayo Clinic Proceedings, 77, 355-361.

    Schneider, K. (2002). Counseling about cancer. New York: Wiley-Liss.

    Shannon, K., Lubratovich, M., Finkelstein, D., Smith, B., Powell, S., & Seiden, M. (2002). Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center. Cancer, 94, 305-313.

    Shattuck-Eidens, D., Oliphant, A., McClure, M., McBride, C., Gupte, J., Rubano, T., et al. (1997). BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA, 278, 1242-1250.

    Stopfer, J. (2000). Genetic counseling and clinical cancer genetics services. Seminars in Surgical Oncology, 18, 347-357.

    Struewing, J., Hartge, P., Wacholder, S., Baker, S., Berlin, M., McAdams, M., et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine, 336, 1401-1408.

    Sweet, K., Bradley, T., & Westman, J. (2002). Identification and referral of families at high risk for cancer susceptibility. Journal of Clinical Oncology, 20, 528-537.

    Tranin, A.S., Masny, A., & Jenkins, J. (2003). Genetics in oncology practice: Cancer risk assessment. Pittsburgh, PA: Oncology Nursing Society.

    Vogel, V. (1996). Assessing women's potential risk of developing breast cancer. Oncology, 10, 1451-1463.

    Weitzel, J. (1999). Genetic cancer risk assessment. Cancer Supplement, 86, 2483-2492.

    Balmain, A., Gray, J., & Ponder, B. (2003). The genetics and genomics of cancer. Nature Genetics Supplement, 33, 238-244.

    Chakravarthy, B., & Peitenpol, J. (2003). Combined modality management of breast cancer: Development of predictive markers through proteomics. Seminars in Oncology, 30(Suppl. 4), 23-36.

    Gibbs, W. (2003). Untangling the roots of cancer. Scientific American, 289(1), 57-65.

    Hanahan, D., & Weinberg, R.A. (2000). The hallmarks of cancer. Cell, 100, 57-70.

    Knudson, A.G. (2002). Cancer genetics. American Journal of Medical Genetics, 111, 96-102.

    Lawrie, L., Fothergill, J., & Murray, G. (2001). Spot the differences: Proteomics in cancer research. Lancet Oncology, 2, 270-277.

    Patterson, S.D., & Aebersold, R.H. (2003). Proteomics: The first decade and beyond. Nature Genetics Supplement, 33, 311-323.

    Ponder, B.AJ. (2001). Cancer genetics. Nature, 411, 336-341.

    Porta, M., Fernandez, E., & Alguacil, J. (2003). Semiology, proteomics, and the early detection of symptomatic cancer. Journal of Clinical Epidemiology, 56, 815-819.

    Verrills, N., & Kavallaris, M. (2003). Drug resistance mechanisms in cancer cells: A proteomics perspective. Current Opinions in Molecular Therapeutics, 5, 258-265.

    Wulfkuhle, J.D., Liotta, L.A., & Petricoin, E.F. (2003). Proteomic applications for the early detection of cancer. Nature Reviews Cancer, 3, 267-275.

    Wulfkuhle, J.D., Paweletz, C.P., Steeg, P.S., Petricoin, E.F., & Liotta, L. (2003). Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Advances in Experimental Medicine and Biology, 532, 59-68.

    Bernhardt, B., Geller, G., Doksum, T., & Metz, S. (2000). Evaluation of nurses and genetic counselors as providers of education about breast cancer susceptibility testing. Oncology Nursing Forum, 27, 33-39.

    Burrer, C., & Bauer, S. (2000). Insights into genetic testing for colon cancer: The nurse practitioner role. Clinical Excellence for Nurse Practitioners, 4, 349-355.

    Calzone, K., Jenkins, J., & Masny, A. (2002). Core competencies in cancer genetics for advanced practice oncology nurses. Oncology Nursing Forum, 29, 1327-1333.

    Greco, K., & Mahon, S. (2003). Genetics nursing practice enters a new era with credentialing. Internet Journal of Advanced Nursing Practice, 5(2). Retrieved January 13, 2004, from

    Greco, K.E. (2000). Cancer genetics nursing: Impact of the double helix. Oncology Nursing Forum, 27(9 Suppl.), 29-36.

    International Society of Nurses in Genetics. (2000). Informed decision-making and consent: The role of the nursing [Position statement]. Retrieved January 13, 2004, from

    International Society of Nurses in Genetics. (2002). Privacy and confidentiality of genetic information: The role of nursing [Position statement]. RetrievedJanuary13,2004,from

    International Society of Nurses in Genetics. (2003). Genetic counseling for vulnerable populations: The role of nursing [Position statement]. Retrieved January 13, 2004, from

    Jenkins, J. (2002). Genetics competency: New directions for nursing. AACN Clinical Issues, 13, 486-491.

    Lea, D.H. (2000). Oncology: Genetics and cancer: Implications for nursing practice. Home Healthcare Consultant, 7(3), 1A-7A.

    MacDonald, D.J. (1997). The oncology nurse's role in cancer risk assessment and counseling. Seminars in Oncology Nursing, 13(2), 123-128.

    Middleton, L., Dimond, E., Calzone, K., Davis, J., & Jenkins, J. (2002). The role of the nurse in cancer genetics. Cancer Nursing, 25, 196-206.

    Olsen, S.J., Feetham, S.L., Jenkins, J., Lewis, J.A., Nissly, T.L., Sigmon, H.D., et al. (2003). Creating a nursing vision for leadership in genetics. Medsurg Nursing, 12(3), 177-183.

    Oncology Nursing Society. (2000). The role of the oncology nurse in cancer genetic counseling [Position statement]. Oncology Nursing Forum, 27, 1348.

    Rieger, P.T. (1998). Overview of cancer and genetics: Implications for nurse practitioners. Nurse Practitioner Forum, 9(3), 122-133.

    Rieger, P.T., & Tinley, S.T. (2000). Cancer genetics and nursing practice: What every gastroen-terology nurse needs to know. Gastroenterology Nursing, 23(1), 28-39.

    Vogel, W.H. (2003). The advanced practice nursing role in a high-risk breast cancer clinic. Oncology Nursing Forum, 30, 115-122.